Ki-67作为区分伯基特淋巴瘤和扩散大B细胞淋巴瘤的标记物:一篇文学评论
Nicyela J Harlendea1, Kent Harlendo2
1Pathology, Tarumanagara University, Jakarta, IDN.
Cureus
|November 25, 2024
概括
基-67是区分伯基特淋巴瘤 (BL) 和扩散性大B细胞淋巴瘤 (DLBCL) 的关键标志物. BL显示接近100%的Ki-67阳性,而DLBCL范围在40-90%之间.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 伯基特淋巴瘤 (BL) 是一种侵袭性的非霍奇金淋巴瘤 (NHL),主要影响儿童.
- 扩散性大B细胞淋巴瘤 (DLBCL) 是全球最常见的NHL,影响成年人.
- 区分BL和DLBCL对于治疗选择至关重要,尽管存在诊断方面的挑战.
研究的目的:
- 审查Ki-67增殖指数在区分伯基特淋巴瘤与扩散大B细胞淋巴瘤中的有用性.
- 探索Ki-67作为在攻击性B细胞淋巴瘤中差异诊断标记物的作用.
主要方法:
- 在MEDLINE,Cochrane,Embase和谷歌学者中进行全面的文献搜索,直到2024年3月.
- 使用的搜索术语包括"Ki-67"",Burkitt淋巴瘤"和"扩散大B细胞淋巴瘤".
- 审查了关于BL,DLBCL和Ki-67标志物的诊断价值的现有文献.
主要成果:
- BL表现出显著更高的Ki-67表达,接近100%的阳性.
- DLBCL通常显示Ki-67阳性度在40%至90%之间.
- Ki-67 作为一种有价值的标记物,用于区分这些侵袭性淋巴瘤.
结论:
- Ki-67是区分伯基特淋巴瘤和扩散型大B细胞淋巴瘤的关键生物标志物.
- 高基-67指数强烈表明伯基特淋巴瘤超过DLBCL.
- 准确的差异化影响NHL患者的治疗策略.
更多相关视频
07:52Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
19.7K
14:30Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
Published on: August 7, 2021
6.5K
相关概念视频
01:20Renal Corpuscle
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...